AIRA Matrix AI Solutions Suite

AIRA Matrix AI Solutions Suite is an artificial intelligence platform developed for healthcare and life sciences applications, with a focus on image analysis and predictive analytics. The platform is designed for pharmaceutical and healthcare organisations seeking to improve analytical workflows across drug discovery, preclinical research, and clinical diagnostics.

The suite combines multimodal data analysis with AI-driven tools to reduce turnaround times, minimise errors, and support more consistent results. It is positioned to extend analytical capabilities beyond what traditional methods support, and to redefine risk stratification and predictive processes in life sciences contexts.

Drug Discovery

• Supports optimisation of time and resources during the drug discovery phase
• Includes predictive toxicology capabilities

Preclinical and Research

• Designed to accelerate preclinical pathology workflows
• Covers quality control functions
• Supports safety assessment processes
• Provides image management for preclinical studies

Clinical Applications

• Intended to support informed therapy decisions
• Includes quality control tools
• Offers prostate diagnostics functionality
• Supports prostate risk stratification
• Provides prostate outcome prediction capabilities

Key Analytical Capabilities

• Image analysis across preclinical and clinical contexts
• Predictive analytics for toxicology and clinical outcomes
• Multimodal data integration for broader analytical insights
• Risk stratification and predictive modelling

Services

• Customised services addressing specific image analysis and study management challenges
• Established deployment frameworks aimed at maintaining efficiency and quality during rapid rollout

AIRA Matrix is headquartered in Thane, Maharashtra, India. The company publishes patents, posters, and scientific publications, and participates in conferences related to AI in digital pathology. A demo of the platform is available on request.